Stock Price Quote

SANOFI INDIA LTD.

NSE : SANOFIBSE : 500674ISIN CODE : INE058A01010Industry : Pharmaceuticals & DrugsHouse : Sanofi India - MNC
BSE6362.0055.55 (+0.88 %)
PREV CLOSE ( ) 6306.45
OPEN PRICE ( ) 6351.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1182
TODAY'S LOW / HIGH ( )6300.00 6393.00
52 WK LOW / HIGH ( )4145.9 10526.05
NSE6366.5060 (+0.95 %)
PREV CLOSE( ) 6306.50
OPEN PRICE ( ) 6370.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 15205
TODAY'S LOW / HIGH( ) 6294.50 6400.00
52 WK LOW / HIGH ( )4902 10524.95
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 02-05 1956
Management Info
Aditya Narayan - Chairman Rodolfo Hrosz - Managing Director
Registered Office

Address Sanofi House, C T S No. 117- B,L & T Business Park,Saki Vihar Road, Powai,
Mumbai,
Maharashtra-400072

Phone 022-2803 2000

Email igrc.sil@sanofi.com

Website www.sanofiindialtd.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX

NEWS

16Apr Sanofi India informs about press release
Sanofi India has informed that it enclosed copies of the newspaper adver..
09Apr Sanofi India informs about compliance
Sanofi India has informed that it enclosed Certificate under Regulation..
13Mar Sanofi India informs about disclosure
In compliance with Regulation 30 of the SEBI (LODR) Regulations, Sanofi..
01Mar Sanofi India informs about press release
Sanofi India has informed that it enclosed copies of the Newspaper publi..
28Feb Sanofi India informs about disclosure
In compliance with Regulation 30 of SEBI (LODR) Regulations, Sanofi Indi..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit9134135
Gross Profit 1222 4314
Operating Profit 12425073
Net Sales 514920132

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE)
peergroup  8942.35 (2.41%)
M.Cap ( in Cr)22137.50
RPG Life Sciences (BSE)
peergroup  2273.40 (4.41%)
M.Cap ( in Cr)3699.28
Pfizer (BSE)
peergroup  4244.00 (1.24%)
M.Cap ( in Cr)19392.46
Samrat Pharmachem (BSE)
peergroup  405.40 (12.50%)
M.Cap ( in Cr)125.44
Mercury Laboratories (BSE)
peergroup  880.10 (4.88%)
M.Cap ( in Cr)106.56

Shareholding Pattern

PROMOTERS 60.4%
FI/BANKS/INSURANCE 11.75%
MUTUAL FUNDS/UTI 11.26%
NON-INSTITUTION 11.01%
GOVERNMENT 0%
FII 0%

About Sanofi India Ltd.

Sanofi India Ltd. was incorporated in the year 1956. Its today's share price is 6362. Its current market capitalisation stands at Rs 14652.43 Cr. In the latest quarter, company has reported Gross Sales of Rs. 29642 Cr and Total Income of Rs.29176 Cr. The company's management includes Arjun Thakkar, Renee Amonkar, Rachid Ayari, Rodolfo Hrosz, Vaibhav Karandikar, Rahul Bhatnagar, Usha Thorat, Aditya Narayan.

It is listed on the BSE with a BSE Code of 500674 , NSE with an NSE Symbol of SANOFI and ISIN of INE058A01010. It's Registered office is at Sanofi House, C T S No. 117- B,L & T Business Park,Saki Vihar Road, PowaiMumbai-400072, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are PC Hansotia & Co, Price Waterhouse & Co, Price Waterhouse & Co Chartered Accountants LLP, SR Batliboi & Co, SR Batliboi & Co LLP, SRBC & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.